Effect of omeprazole intake on faecal calprotectin

inköping university0 个研究点目标入组 32 人开始时间: 2016年9月1日最近更新: 2022年3月28日

适应症

试验速览

暂无简介。

•age 18 – 64 years
•healthy individuals (individuals who are not known to suffer of any significant illness relevant to this study and should be within the ordinary range of body measurements, such as weight, and whose mental state is such that they are able to understand and give valid consent to the study; they should not have any disease or condition requiring regular medication)
•written informed consent signed
•normal faecal calprotectin test, blood count and Helicobacter pylori test
•regular bowel movements
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 32
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•PPI, NSAID or ASA (acetyl salicylic acid) intake in the past month
•history of regular PPI, NSAID or ASA use
•intolerance to PPIs or NSAIDs
•history of gastrointestinal diseases or bleeding
•conditions associated with bleeding disorders
•asthma, cirrhosis, hepatic porphyria, liver failure, kidney failure, heart failure, ischemic heart disease, peripheral arterial disease and cerebrovascular disease
•pregnancy or lactating
•current alcohol misuse
•participation in another clinical trial involving medicinal products within 30 days

发起方

inköping university